A Coruña
Studies
Despite the more aggressive behavior of GH&PRL-PitNETs compared to Somatotroph pituitary neuroendocrine tumors, there were no significant differences in the rate of IGF-1 control between the two drugs (pegvisomant and pasireotide) in either patient group. Both drugs were effective in controlling IGF-1 and PRL hypersecretion in the tumors studied. The study found that pegvisomant and pasireotide are both effective treatments for controlling IGF-1 and PRL hypersecretion in patients with GH&PRL-Pit-NETs and GH-Pit-NETs, with no substantial differences in efficacy between the two drugs 1).
Glucose metabolism improved in patients with acromegaly after surgery and 21% of the diabetic patients experienced diabetes remission; being more frequent in patients of older age, and those who experienced surgical cure and those with preserved anterior pituitary function after surgery 2).
Department
Department of Neurosurgery, Hospital HM Modelo, A Coruña, Spain (Dr Garcia-Fantini)
2016
Synergistic Increase of Serum BDNF in Alzheimer Patients Treated with Cerebrolysin and Donepezil: Association with Cognitive Improvement in ApoE4 Cases
2015
Vivid Mental Imagery of Biomechanically Impossible Movements Elicited by Cortical Electrostimulation of the Central Region in an Awake Patient